Description

Three companies provide clarifications to stock exchanges regarding significant increase in trading volume of their shares.

Summary

BSE Limited sought clarifications from three listed companies regarding significant increases in trading volume of their shares. Dolat Algotech Limited (Scrip Code: 505526), Eris Lifesciences Limited (Security Code: 540596), and Inox Green Energy Services Limited responded to surveillance queries, confirming that all material information has been duly disclosed to stock exchanges in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. All three companies stated there is no undisclosed development or pending information that could explain the volume increase.

Key Points

  • Dolat Algotech Limited, Eris Lifesciences Limited, and Inox Green Energy Services Limited received surveillance queries from BSE regarding volume increases
  • All companies confirmed compliance with Regulation 30 of SEBI (LODR) Regulations, 2015
  • No material undisclosed information exists that could explain the trading volume surge
  • Companies attribute volume increases to market-driven conditions
  • All material information has been timely disclosed to stock exchanges and is available in public domain

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

No new compliance requirements. Companies reaffirm existing obligations:

  • Timely disclosure of all material information under Regulation 30 of SEBI (LODR) Regulations, 2015
  • Compliance with insider trading regulations
  • Responding to stock exchange surveillance queries

Important Dates

  • December 10, 2025: Date of clarification submissions to BSE Limited and NSE

Impact Assessment

This is a routine surveillance matter with minimal market impact. The clarifications indicate:

  • No unexpected corporate developments or material events
  • Trading volume increases are attributed to normal market dynamics
  • Investor confidence in disclosure practices is maintained through transparent responses
  • No regulatory action or trading restrictions anticipated
  • Market participants can rely on publicly available information for investment decisions

Impact Justification

Routine surveillance clarifications with no material non-public information disclosed; companies confirm compliance with disclosure norms